The Beauty Health Company
NASDAQ:SKINHousehold & Personal Products
+$0.04 today
- Market cap
- $81.18M
- Beta
- 1.07
- P/E (TTM)
- -14.6
- EPS (TTM)
- -$0.05
Volume 0.05M
Average 0.95M
SKIN Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
The Beauty Health CompanyNASDAQ: SKIN
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash turns negative
Q1 FY2026 net change in cash was -$28.3M, compared with $2.97M a year earlier. Trailing-twelve-month net change in cash was -$168.66M. Over 3 fiscal years it compounded at -25.6% a year.
Context
- Net change in cash amounted to 45.7% of revenue in FY2025, unchanged from a year earlier.
- Net change in cash grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly net change in cash holds near -$28.3M or moves back toward the trailing-twelve-month quarterly average of -$42.16M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- (137.4M) USD
- Year-over-year change
- +10.2%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (137.4M) | +10.2% |
| FY2024 | 2024-12-31 | (152.96M) | -238.6% |
| FY2023 | 2023-12-31 | (45.17M) | +86.5% |
| FY2022 | 2022-12-31 | (333.69M) | -137.4% |
| FY2021 | 2021-12-31 | 892.4M | — |
Net Change in Cash vs competitors
How SKIN compares with its peers on the latest reported figures
- Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +135.5% is the 3rd highest of 7, against a peer median of +71.0%.
- Net change in cash amounts to 57.0% of revenue for SKIN, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $168.66M USD | +135.5% | -25.6% | 57.0% | |
| FY2025 | CN¥17.69M CNY | +130.0% | — | 1.0% | |
| LTM Mar 2026 | $4.8M USD | -277.6% | — | 5.3% | |
| LTM Apr 2026 | $4.69M USD | -74.9% | -49.1% | 1.0% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $1.24M USD | +518.9% | — | 2.1% |
| LTM Mar 2026 | $1.12M USD | +12.0% | — | 0.7% | |
| LTM Mar 2026 | $750K USD | +196.8% | — | 0.4% | |
| Peer median (excluding SKIN) | — | +71.0% | -49.1% | 1.0% | |
Competitors are the stored peer set for SKIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (375.11M) | 44.38M | (100.12M) | (29.1M) | (9.5M) |
| Depreciation & Amortization | 21.14M | 22.02M | 34.68M | 33.68M | 25.35M |
| Deferred Income Tax | (3.76M) | (1.79M) | (1.08M) | (3.75M) | 2.22M |
| Stock-Based Compensation | 12.42M | 28.5M | 22.54M | 26.7M | 14.82M |
| Change in Working Capital | (18.66M) | (140.28M) | 23.36M | (27.39M) | 10.37M |
| Accounts Receivables | (31.01M) | (32.03M) | 12.85M | 20.8M | 8.59M |
| Inventory | (9.44M) | (82.1M) | 19.57M | (10.5M) | 15.8M |
| Accounts Payables | 10.52M | 1.61M | 15.78M | (43.78M) | (7.2M) |
| Other Working Capital | 11.27M | (27.77M) | (24.85M) | 6.08M | (6.83M) |
| Other Non-Cash Items | 335.62M | (59.43M) | 41.29M | 16M | 36.63M |
| Operating Cash Flow | (28.36M) | (106.6M) | 21.75M | 16.13M | 37.5M |
| Capital Expenditures | (15.62M) | (17.39M) | (13.05M) | (6.79M) | (303K) |
| Acquisitions (Net) | (22.9M) | (1.48M) | (18.46M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 781K | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (37.73M) | (18.87M) | (31.51M) | (6.79M) | (5.16M) |
| Debt Repayment | 524.51M | 0 | 0 | (156.08M) | (173.35M) |
| Common Stock Issued | 938.38M | 0 | 0 | 0 | (1.57M) |
| Common Stock Repurchased | 0 | (160M) | (32.4M) | (1.96M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (503.86M) | (45.24M) | (1.82M) | (302K) | 26K |
| Financing Cash Flow | 959.04M | (205.24M) | (37.45M) | (158.34M) | (174.9M) |
| Effect of Forex Changes | (543K) | (2.98M) | 2.03M | (3.96M) | 5.21M |
| Net Change in Cash | 892.4M | (333.69M) | (45.17M) | (152.96M) | (137.4M) |
| Free Cash Flow | (43.98M) | (123.99M) | 8.7M | 9.34M | 37.18M |
The Beauty Health Company
NASDAQ:SKIN
Intrinsic Alpha fair value
Locked
Current Price
$12.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.